Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,089,983 papers from all fields of science
Search
Sign In
Create Free Account
patiromer
Known as:
Patiromer FOS
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (1)
Polymers
Narrower (2)
RLY 5016
Veltassa
patiromer 25200 MG Powder for Oral Suspension [Veltassa]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The Management of Co-Morbidities in Patients with Heart Failure – Potassium Balance
E. Jankowska
2017
Corpus ID: 80206991
Both hypokalaemia and hyperkalaemia are common in HF patients. They are each associated both with HF and with the many drugs used…
Expand
2017
2017
Abstract 14680: Effect of Patiromer in Hyperkalemic Patients With or Without RAASi
R. Kloner
,
Coleman Gross
,
Jinwei Yuan
,
A. Conrad
,
P. Pergola
2017
Corpus ID: 86714037
Introduction: Hyperkalemia (HK) affects HF patients (pts) with renal disease even if not on RAASi. Prior studies of patiromer, a…
Expand
2017
2017
Erhöhte Kaliumspiegel anhaltend senken
Silke Wedekind
Info Diabetologie
2017
Corpus ID: 56943741
Überhöhte Kaliumspiegel im Serum können den Sinusrhythmus stören, zu Kammerflimmern und zu Herzversagen führen. Patiromer erm…
Expand
2016
2016
Patiromer sorbitex calcium
杨华丽
,
程卯生
2016
Corpus ID: 103893163
Patiromer sorbitex calcium由Relypsa公司研制开发,商品名为Veltassa。该药是一种非吸收的钾结合剂,于2015年10月21日批准上市,适用于高血压及高血钾症的治疗,但不适用于严重高血钾症的紧急治疗。
2013
2013
Patiromer, nouveau traitement de l’hyperkaliémie
J. Manus
2013
Corpus ID: 68019733